Skip to main content
. 2013 Nov 16;13:178. doi: 10.1186/1471-2377-13-178

Figure 1.

Figure 1

Levels of miR-30a in plasma samples of patients with ischemic stroke at 24 h, 1 w, 4 w, 24 w and 48 w after the onset of symptoms. (A) The levels of miR-30a-LA at different time points; (B) The levels of miR-30a-SA at different time points; (C) The levels of miR-30a-CEmb at different time points; (D) The levels of miR-30a-UDN at different time points (* vs. control, p < 0.05).